The neurobiology of depression—revisiting the serotonin hypothesis. II. Genetic, epigenetic and clinical studies†

The serotonin system originates from a small number of neurons (a few hundred thousand of the 100 billion in man) located in the midbrain raphe nuclei, that project widely throughout the central nervous system to influence a large array of inter-related biological functions, not least of which are circuits involved in mood and emotion. The serotonin hypothesis of depression has postulated that a reduction in serotonin leads to increased predisposition to depression. Indeed, it has become evident from therapeutic strategies that affect serotonin activity, that alterations in serotonin may not only predispose to depression, but also to aggressive behaviour, impulsivity, obsessive–compulsive behaviour and suicide. Many potential mechanisms known to alter the genes that regulate the serotonin system, including developmental epigenetic modifications, are presented, as additional evidence implicating the serotonin system. This second issue of two special issues of Philosophical Transactions B presents a series of reviews, perspectives and new findings that argue that the serotonin hypothesis remains an important idea that continues to guide research into the aetiology and treatment of depression.

[1]  R. Parsey,et al.  Imaging the serotonin 1A receptor using [11C]WAY100635 in healthy controls and major depression , 2013, Philosophical Transactions of the Royal Society B: Biological Sciences.

[2]  M. Weissman,et al.  Using the high-risk family design to identify biomarkers for major depression , 2013, Philosophical Transactions of the Royal Society B: Biological Sciences.

[3]  M. Szyf,et al.  Looking beyond the DNA sequence: the relevance of DNA methylation processes for the stress–diathesis model of depression , 2013, Philosophical Transactions of the Royal Society B: Biological Sciences.

[4]  S. Young,et al.  The effect of raising and lowering tryptophan levels on human mood and social behaviour , 2013, Philosophical Transactions of the Royal Society B: Biological Sciences.

[5]  J. Mann,et al.  The serotonergic system in mood disorders and suicidal behaviour , 2013, Philosophical Transactions of the Royal Society B: Biological Sciences.

[6]  P. Cowen,et al.  ‘It's the way that you look at it’—a cognitive neuropsychological account of SSRI action in depression , 2013, Philosophical Transactions of the Royal Society B: Biological Sciences.

[7]  A. Hariri,et al.  Identifying serotonergic mechanisms underlying the corticolimbic response to threat in humans , 2013, Philosophical Transactions of the Royal Society B: Biological Sciences.

[8]  D. Goldman,et al.  Genetics of impulsive behaviour , 2013, Philosophical Transactions of the Royal Society B: Biological Sciences.

[9]  P. Blier,et al.  Serotonin and beyond: therapeutics for major depression , 2013, Philosophical Transactions of the Royal Society B: Biological Sciences.

[10]  D. Murphy,et al.  Anxiety and affective disorder comorbidity related to serotonin and other neurotransmitter systems: obsessive–compulsive disorder as an example of overlapping clinical and genetic heterogeneity , 2013, Philosophical Transactions of the Royal Society B: Biological Sciences.

[11]  P. Albert Transcriptional regulation of the 5-HT1A receptor: implications for mental illness , 2012, Philosophical Transactions of the Royal Society B: Biological Sciences.

[12]  L. Descarries,et al.  Effects of the antidepressant fluoxetine on the subcellular localization of 5-HT1A receptors and SERT , 2012, Philosophical Transactions of the Royal Society B: Biological Sciences.

[13]  A. Heath,et al.  Heritability of Delay Discounting in Adolescence: A Longitudinal Twin Study , 2011, Behavior genetics.

[14]  Gustavo Turecki,et al.  Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse , 2009, Nature Neuroscience.

[15]  Patrick M Fisher,et al.  Effects of HTR1A C(-1019)G on amygdala reactivity and trait anxiety. , 2009, Archives of general psychiatry.

[16]  L. Descarries,et al.  MicroPET imaging of 5-HT1A receptors in rat brain: a test–retest [18F]MPPF study , 2008, European Journal of Nuclear Medicine and Molecular Imaging.

[17]  B. Lebowitz,et al.  Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. , 2006, The American journal of psychiatry.

[18]  Laurent Descarries,et al.  Acute Treatment with the Antidepressant Fluoxetine Internalizes 5-HT1A Autoreceptors and Reduces the In Vivo Binding of the PET Radioligand [18F]MPPF in the Nucleus Raphe Dorsalis of Rat , 2004, The Journal of Neuroscience.

[19]  G. Rajkowska,et al.  Depression: What We can Learn from Postmortem Studies , 2003, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[20]  P. Sullivan,et al.  Genetic epidemiology of major depression: review and meta-analysis. , 2000, The American journal of psychiatry.

[21]  Laurent Descarries,et al.  Quantitative data on serotonin nerve terminals in adult rat neocortex , 1976, Brain Research.

[22]  L. Descarries,et al.  Serotonin nerve terminals in adult rat neocortex , 1975, Brain Research.